Concepedia

Michael Keng

MK

12

Publications

350

Citations

12

H-Index

2003

Active since

Affiliations

University of Virginia(Current)

Cleveland Clinic

Dana-Farber Cancer Institute

Beth Israel Deaconess Medical Center

Brigham and Women's Hospital

Michael Keng is an author at University of Virginia specializing in medicine, hematology, and cancer research.

ORCID

Top concepts

Publications per year

2003–2022

12

Publications

12

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

Michael B. Maris, Michael Boeckh, Barry E. Storer et al. · Experimental Hematology · 2003 · 98 citations · Full text

, , +7

Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department

Michael Keng, Elaine Thallner, Paul Elson et al. · Journal of Oncology Practice · 2015 · 59 citations · Full text

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Jacqueline S. Garcia, Yael Flamand, Livius Penter et al. · Blood · 2022 · 46 citations · Full text

, , +21

Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy

Moshe Chaim Ornstein, Sudipto Mukherjee, Michael Keng et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 21 citations

, , +15

Synergism between Arsenic Trioxide and Heat Shock Protein 90 Inhibitors on Signal Transducer and Activator of Transcription Protein 3 Activity—Pharmacodynamic Drug-Drug Interaction Modeling

Meir Wetzler, Justin Earp, Michael T. Brady et al. · Clinical Cancer Research · 2007 · 19 citations · Full text

Rows per page

1–5 of 12